These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18337526)

  • 1. Is the use of letrozole to induce ovulation teratogenic?
    Gill SK; Moretti M; Koren G
    Can Fam Physician; 2008 Mar; 54(3):353-4. PubMed ID: 18337526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal safety of letrozole and clomiphene citrate for ovulation induction.
    Forman R; Gill S; Moretti M; Tulandi T; Koren G; Casper R
    J Obstet Gynaecol Can; 2007 Aug; 29(8):668-71. PubMed ID: 17714621
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the pregnancy outcomes and the incidence of fetal congenital abnormalities in infertile women treated with letrozole and clomiphene citrate.
    Akbari Sene A; Ghorbani S; Ashrafi M
    J Obstet Gynaecol Res; 2018 Jun; 44(6):1036-1041. PubMed ID: 29924470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ovulation induction by means of letrozole].
    Ekerhovd E
    Tidsskr Nor Laegeforen; 2009 Feb; 129(5):412-5. PubMed ID: 19247401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the aromatase inhibitor letrozole for ovulation induction in women with polycystic ovarian syndrome.
    Casper RF; Mitwally MF
    Clin Obstet Gynecol; 2011 Dec; 54(4):685-95. PubMed ID: 22031258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aromatase inhibitors for subfertile women with polycystic ovary syndrome.
    Franik S; Kremer JA; Nelen WL; Farquhar C
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010287. PubMed ID: 24563180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology.
    Tatsumi T; Jwa SC; Kuwahara A; Irahara M; Kubota T; Saito H
    Hum Reprod; 2017 Jan; 32(1):125-132. PubMed ID: 27821708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatment outcomes of infertile women by clomiphene citrate and letrozole with gonadotropins underwent intrauterine insemination.
    Zadehmodares S; Niyakan M; Sharafy SA; Yazdi MH; Jahed F
    Acta Med Iran; 2012; 50(1):18-20. PubMed ID: 22267373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letrozole versus clomiphene citrate: which is better for ovulation induction?
    Casper RF
    Fertil Steril; 2009 Sep; 92(3):858-859. PubMed ID: 17588568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital malformations among babies born following letrozole or clomiphene for infertility treatment.
    Sharma S; Ghosh S; Singh S; Chakravarty A; Ganesh A; Rajani S; Chakravarty BN
    PLoS One; 2014; 9(10):e108219. PubMed ID: 25272289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy of aromatase inhibitor and clomiphene citrate in induction of ovulation in polycystic ovarian syndrome.
    Begum MR; Ferdous J; Begum A; Quadir E
    Fertil Steril; 2009 Sep; 92(3):853-857. PubMed ID: 18177867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles.
    Tatsumi T; Jwa SC; Kuwahara A; Irahara M; Kubota T; Saito H
    Hum Reprod; 2017 Jun; 32(6):1244-1248. PubMed ID: 28398491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limiting access to letrozole--is it justified?
    Tulandi T; DeCherney AH
    Fertil Steril; 2007 Oct; 88(4):779-80. PubMed ID: 17462638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome.
    Amer SA; Smith J; Mahran A; Fox P; Fakis A
    Hum Reprod; 2017 Aug; 32(8):1631-1638. PubMed ID: 28854590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of gingival inflammation in patients using ovulation induction drugs before and after scaling.
    Vasudevan S; Renuka JV; Sylvia DS; Challa R; Padmakanth M; Reddy A
    J Contemp Dent Pract; 2013 Nov; 14(6):1165-8. PubMed ID: 24858769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Letrozole-HMG and Clomiphene-HMG on Incidence of Luteinized Unruptured Follicle Syndrome in Infertile Women Undergoing Induction Ovulation and Intrauterine Insemination: A Randomised Trial.
    Azmoodeh A; Pejman Manesh M; Akbari Asbagh F; Ghaseminejad A; Hamzehgardeshi Z
    Glob J Health Sci; 2015 Sep; 8(4):244-52. PubMed ID: 26573024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letrozole in ovulation induction: time to make decisions.
    Polyzos NP; Mauri D; Tzioras S
    Hum Reprod Update; 2009; 15(2):263-4. PubMed ID: 18987099
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
    Bjelica A; Trninić-Pjević A; Mladenović-Segedi L; Cetković N; Petrović D
    Srp Arh Celok Lek; 2016; 144(3-4):146-50. PubMed ID: 27483558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of aromatase inhibitors for ovulation induction.
    Klement AH; Casper RF
    Curr Opin Obstet Gynecol; 2015 Jun; 27(3):206-9. PubMed ID: 25710389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.